Ruth E. Winecker

1.2k total citations
46 papers, 813 citations indexed

About

Ruth E. Winecker is a scholar working on Toxicology, Pharmacology and Emergency Medicine. According to data from OpenAlex, Ruth E. Winecker has authored 46 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Toxicology, 17 papers in Pharmacology and 11 papers in Emergency Medicine. Recurrent topics in Ruth E. Winecker's work include Forensic Toxicology and Drug Analysis (29 papers), Cannabis and Cannabinoid Research (15 papers) and Poisoning and overdose treatments (10 papers). Ruth E. Winecker is often cited by papers focused on Forensic Toxicology and Drug Analysis (29 papers), Cannabis and Cannabinoid Research (15 papers) and Poisoning and overdose treatments (10 papers). Ruth E. Winecker collaborates with scholars based in United States, Canada and Sweden. Ruth E. Winecker's co-authors include Jeri D. Ropero‐Miller, Catherine A. Hammett‐Stabler, Larry A. Broussard, Ronald Flegel, David C. Winston, Edward J. Cone, Tory R. Spindle, Ryan G. Vandrey, John M. Mitchell and George E. Bigelow and has published in prestigious journals such as Drug and Alcohol Dependence, JAMA Network Open and Journal of Forensic Sciences.

In The Last Decade

Ruth E. Winecker

42 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth E. Winecker United States 17 262 258 176 169 115 46 813
Stéphane Pirnay France 16 255 1.0× 178 0.7× 247 1.4× 91 0.5× 105 0.9× 31 754
Mark K. Su United States 16 275 1.0× 216 0.8× 103 0.6× 240 1.4× 54 0.5× 76 801
David L. Black United States 18 354 1.4× 126 0.5× 228 1.3× 83 0.5× 76 0.7× 35 851
Matthew H. Slawson United States 20 287 1.1× 160 0.6× 145 0.8× 76 0.4× 187 1.6× 35 1.2k
Susan C. Smolinske United States 22 171 0.7× 231 0.9× 83 0.5× 286 1.7× 60 0.5× 52 1.2k
Maryam Akhgari Iran 16 163 0.6× 133 0.5× 147 0.8× 162 1.0× 37 0.3× 52 928
Merja Gergov Finland 21 490 1.9× 172 0.7× 212 1.2× 109 0.6× 97 0.8× 31 1.5k
Charles LoDico United States 14 259 1.0× 435 1.7× 84 0.5× 56 0.3× 122 1.1× 18 737
Anne‐Laure Pélissier‐Alicot France 16 289 1.1× 290 1.1× 70 0.4× 191 1.1× 136 1.2× 68 836
Stefanie Iwersen‐Bergmann Germany 17 642 2.5× 244 0.9× 174 1.0× 255 1.5× 86 0.7× 62 1.5k

Countries citing papers authored by Ruth E. Winecker

Since Specialization
Citations

This map shows the geographic impact of Ruth E. Winecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth E. Winecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth E. Winecker more than expected).

Fields of papers citing papers by Ruth E. Winecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth E. Winecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth E. Winecker. The network helps show where Ruth E. Winecker may publish in the future.

Co-authorship network of co-authors of Ruth E. Winecker

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth E. Winecker. A scholar is included among the top collaborators of Ruth E. Winecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth E. Winecker. Ruth E. Winecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zamarripa, C. Austin, Tory R. Spindle, Edward J. Cone, et al.. (2025). A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults. Drug and Alcohol Dependence. 272. 112676–112676.
2.
Chronister, Chris W., Gregory G. Davis, Teresa R Gray, et al.. (2025). Application of professional best practices in postmortem forensic toxicology. Journal of Analytical Toxicology. 49(8). 529–541.
3.
Vikingsson, Svante, Ruth E. Winecker, Eugene D Hayes, et al.. (2024). Stability of Nano-Emulsified Cannabidiol in Acidic Foods and Beverages. Cannabis and Cannabinoid Research. 10(2). 213–219. 1 indexed citations
4.
Vikingsson, Svante, et al.. (2024). Fentanyl as a marker of illicit drug use in morphine-positive urine specimens from workplace drug testing. Journal of Analytical Toxicology. 48(3). 185–190. 2 indexed citations
5.
Vikingsson, Svante, et al.. (2023). Conversion of water-soluble CBD to ∆9-THC in synthetic gastric fluid—An unlikely cause of positive drug tests. Journal of Analytical Toxicology. 47(7). 632–635. 2 indexed citations
6.
Vikingsson, Svante, et al.. (2023). ∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods. Journal of Analytical Toxicology. 47(7). 557–562. 5 indexed citations
7.
Vikingsson, Svante, Ruth E. Winecker, Edward J. Cone, et al.. (2023). Prevalence of ∆8-tetrahydrocannabinol carboxylic acid in workplace drug testing. Journal of Analytical Toxicology. 47(8). 719–725. 6 indexed citations
8.
Spindle, Tory R., Dennis J. Sholler, Edward J. Cone, et al.. (2022). Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores. JAMA Network Open. 5(7). e2223019–e2223019. 36 indexed citations
9.
Vikingsson, Svante, Ruth E. Winecker, Edward J. Cone, et al.. (2022). Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens. Journal of Analytical Toxicology. 46(8). 866–874. 6 indexed citations
10.
Davis, Gregory G., Amy B. Cadwallader, Corinne L. Fligner, et al.. (2020). Position Paper. American Journal of Forensic Medicine & Pathology. 41(3). 152–159. 38 indexed citations
11.
Slavova, Svetla, Alison Miller, Terry L. Bunn, et al.. (2018). Prevalence of gabapentin in drug overdose postmortem toxicology testing results. Drug and Alcohol Dependence. 186. 80–85. 53 indexed citations
12.
Beal, Jennifer, et al.. (2016). Loperamide-Related Deaths in North Carolina. Journal of Analytical Toxicology. 40(8). 677–686. 42 indexed citations
13.
Miller, Alison, et al.. (2015). Postmortem Metaxalone (Skelaxin®) Data from North Carolina. Journal of Analytical Toxicology. 39(8). 629–636. 2 indexed citations
14.
Kornegay, Nancy, et al.. (2012). Postmortem Levetiracetam (Keppra) Data from North Carolina. Journal of Analytical Toxicology. 36(6). 422–428. 5 indexed citations
15.
Hargrove, Richard, et al.. (2009). Concentration of Oxymorphone in Postmortem Fluids and Tissue. Journal of Analytical Toxicology. 33(3). 121–128. 23 indexed citations
16.
Winecker, Ruth E.. (2009). Quantification of Antidepressants Using Gas Chromatography-Mass Spectrometry. Methods in molecular biology. 603. 45–56. 9 indexed citations
17.
Winecker, Ruth E., et al.. (2008). Unusual Fentanyl Patch Administration. American Journal of Forensic Medicine & Pathology. 29(2). 162–163. 16 indexed citations
18.
Poklis, Justin L., et al.. (2007). Postmortem Memantine Concentrations. Journal of Analytical Toxicology. 31(4). 233–236. 1 indexed citations
19.
Poklis, Justin L., et al.. (2004). Metaxalone (Skelaxin(R))-Related Death. Journal of Analytical Toxicology. 28(6). 537–540. 10 indexed citations
20.
Winecker, Ruth E., Dan Garside, & Jeri D. Ropero‐Miller. (2004). Case report: Metaxalone (Skelaxin®)-Related Death. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphane Pirnay Breakdown of academic impact, for papers by Mark K. Su Breakdown of academic impact, for papers by David L. Black Breakdown of academic impact, for papers by Matthew H. Slawson Breakdown of academic impact, for papers by Susan C. Smolinske Breakdown of academic impact, for papers by Maryam Akhgari Breakdown of academic impact, for papers by Merja Gergov Breakdown of academic impact, for papers by Charles LoDico Breakdown of academic impact, for papers by Anne‐Laure Pélissier‐Alicot Breakdown of academic impact, for papers by Stefanie Iwersen‐Bergmann
Rankless by CCL
2026